Literature DB >> 27145702

Tackling antimicrobial resistance in France.

Marisol Touraine1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27145702     DOI： 10.1016/S0140-6736(16)30356-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Comparison of governance approaches for the control of antimicrobial resistance: Analysis of three European countries.

Authors:  Gabriel Birgand; Enrique Castro-Sánchez; Sonja Hansen; Petra Gastmeier; Jean-Christophe Lucet; Ewan Ferlie; Alison Holmes; Raheelah Ahmad
Journal:  Antimicrob Resist Infect Control       Date:  2018-02-20       Impact factor: 4.887

2.  The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.

Authors:  Jean-Winoc Decousser; Paul-Louis Woerther; Claude-James Soussy; Marguerite Fines-Guyon; Michael J Dowzicky
Journal:  Antimicrob Resist Infect Control       Date:  2018-05-30       Impact factor: 4.887

Review 3.  Policy and strategies addressing prevention and control of antimicrobial resistance in Brazil: A scoping review protocol.

Authors:  Joslaine de Oliveira Nunes; Raissa Allan Santos Domingues; Roberto Mauro Pinto Coelho Barcellos; Bárbara Manuella Cardoso Sodré Alves; Isis Polianna Silva Ferreira de Carvalho; Noemia Urruth Leão Tavares
Journal:  PLoS One       Date:  2022-01-28       Impact factor: 3.240

4.  Trends in Antibiotic Consumption and Resistance in France Over 20 Years: Large and Continuous Efforts but Contrasting Results.

Authors:  Jean Carlet; Vincent Jarlier; Jacques Acar; Olivier Debaere; Patrick Dehaumont; Bruno Grandbastien; Pierre Le Coz; Gerard Lina; Yves Pean; Claude Rambaud; France Roblot; Jérôme Salomon; Benoit Schlemmer; Pierre Tattevin; Benoit Vallet
Journal:  Open Forum Infect Dis       Date:  2020-11-06       Impact factor: 3.835
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.